Recombinant Human IL36G/IL1F9 Protein (aa 18-169)

Introducing the Recombinant Human IL36G/IL1F9 Protein (aa 18-169), a cutting-edge biotechnological advancement in the field of immunology. This meticulously engineered protein is derived from the human interleukin-36 gamma (IL36G) or interleukin-1 family member 9 (IL1F9) gene, encompassing amino acids 18 to 169.

Crafted with utmost precision and adhering to the highest quality standards, this recombinant protein offers a multitude of potential applications in various research areas. Its unique composition enables the investigation of intricate cellular processes, particularly those associated with immune responses and inflammatory reactions.

The Recombinant Human IL36G/IL1F9 Protein (aa 18-169) exhibits exceptional purity and bioactivity, ensuring reliable and reproducible results in experimental settings. Its structural integrity and functional properties have been rigorously validated through meticulous testing, guaranteeing optimal performance and accuracy.

This protein serves as an invaluable tool for scientists and researchers seeking to unravel the complexities of immune regulation and inflammatory pathways. Its versatile nature allows for a wide range of applications, including but not limited to in vitro studies, protein-protein interaction assays, and functional analysis of immune cells.

With its remarkable attributes and unrivaled efficacy, the Recombinant Human IL36G/IL1F9 Protein (aa 18-169) stands as a beacon of innovation in the realm of immunological research. Embrace this groundbreaking advancement and unlock new frontiers in understanding the intricate mechanisms governing immune responses and inflammatory processes.